Andrii Buvailo - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Andrii Buvailo's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Andrii Buvailo

Andrii Buvailo

Verified

Co-Founder and Editor-in-Chief, BiopharmaTrend

Valencia

Final Covers

Conflict , Health , Religion , Human Rights , Education , Women’s Issues

Doesn’t Cover

finance, real estate

Journalist Type

Industries

Medium Formats

Content

Total articles 38

  • The Rise of AI Agents in Biotech, Where Are We Now?

    By Andrii Buvailo Verified, Biopharma Trend| Where Tech Meets Bio@ In today's deep dive, guest contributor takes us through the current state of AI agents in biotech, exploring their technical foundations and early-stage applications. There's been a growing buzz around “AI agents” across the tech ecosystem, with promises of autonomy, automation, and accelerated discovery. In biotech and drug development, however, their real-world presence is still early-stage.

    By Andrii Buvailo Verified, Biopharma Trend · Where Tech Meets Bio

    Apr. 10, 2025

  • Study: Trust in Scientists Post-Pandemic Remains High, but Public Wants More Engagement

    By Andrii Buvailo Verified| BiopharmaTrend Verified Led by researchers from Harvard University, ETH Zurich, and the University of Zurich, a recent international study sheds light on public perceptions of scientists and their role in society. This large-scale research, which engaged over 71,922 respondents from 68 countries, reveals that trust in scientists remains high worldwide and offers a snapshot of global attitudes toward science since the COVID-19 pandemic.

    By Andrii Buvailo Verified · BiopharmaTrend

    Jan. 20, 2025

  • The Rise of AI Agents in Biotech, Where Are We Now?

    By Andrii Buvailo Verified, Biopharma Trend| Where Tech Meets Bio@ In today's deep dive, guest contributor takes us through the current state of AI agents in biotech, exploring their technical foundations and early-stage applications. There's been a growing buzz around “AI agents” across the tech ecosystem, with promises of autonomy, automation, and accelerated discovery. In biotech and drug development, however, their real-world presence is still early-stage.

    By Andrii Buvailo Verified, Biopharma Trend · Where Tech Meets Bio

    Apr. 10, 2025

As seen in

Company Info

BiopharmaTrend

BioPharmaTrend.com is a London-based digital platform established in 2016. It focuses on providing news, trends, and analysis for the biotechnology, pharmaceutical, and healthcare sectors. The platform serves professionals looking for insights into technological advancements, investment trends, and industry events. The company offers a range of services, including industry insights through market research and technology scouting, as well as content streams featuring articles, interviews, and case studies. It also provides educational resources that simplify complex topics for decision-makers in the life sciences field. Additionally, BioPharmaTrend.com collaborates with an advisory board to ensure the relevance and accuracy of its content. Targeting investors, business leaders, consultants, and government professionals, BioPharmaTrend.com aims to deliver reliable insights that support informed decision-making in the biopharma and healthcare industries.

Founded: 2016